Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses.

摘要

The VISP subgroup analysis4 excluded patients with B12 deficiency (because they were all receiving injections of cya-nocobalamin, regardless of the treatment to which they were randomized), and patients with significant renal impairment (because it was thought they would not respond to vitamin therapy).